ACS Pharmacol Transl Sci
November 2024
Tacrolimus (TAC) has a narrow therapeutic index and shows interindividual variabilities in its blood concentration. Although guidelines recommend a genetic variant (rs776746) to determine the optimized TAC dose, discrepancies in accuracy have been noted. Therefore, studying other variants of may improve the accuracy of the TAC dose.
View Article and Find Full Text PDFBackground: Catalytic iron (CI) mediates vascular injury by generating reactive oxygen species. We evaluated role of CI in predicting mortality in patients with acute coronary syndrome (ACS) and studied association of contrast nephropathy with CI levels.
Methods: We investigated 806 patients with ACS undergoing contrast exposure for a cardiac procedure who were followed up for 30 days.